233 related articles for article (PubMed ID: 8462606)
1. Comparison of simultaneous 99mTc-HMPAO and 111In oxine labelled white cell scans in the assessment of inflammatory bowel disease.
Allan RA; Sladen GE; Bassingham S; Lazarus C; Clarke SE; Fogelman I
Eur J Nucl Med; 1993 Mar; 20(3):195-200. PubMed ID: 8462606
[TBL] [Abstract][Full Text] [Related]
2. Value of technetium-99m HMPAO-labelled leucocyte scintigraphy as an initial screening test in patients suspected of having inflammatory bowel disease.
Giaffer MH; Tindale WB; Holdsworth D
Eur J Gastroenterol Hepatol; 1996 Dec; 8(12):1195-200. PubMed ID: 8980940
[TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment of overall inflammatory bowel disease activity using labelled leucocytes: a direct comparison between indium-111 and technetium-99m HMPAO methods.
Mansfield JC; Giaffer MH; Tindale WB; Holdsworth CD
Gut; 1995 Nov; 37(5):679-83. PubMed ID: 8549945
[TBL] [Abstract][Full Text] [Related]
4. Imaging of inflammatory bowel disease (IBD) and scintigraphic assessment of resected colon: comparison of 111 In-oxine and 99mTC HMPAO leucocyte labelling.
Moisan A; Lecloirec J; Bretagne JF; Loreal O; Raoul JL; Herry JY
Prog Clin Biol Res; 1990; 355():159-64. PubMed ID: 2126373
[No Abstract] [Full Text] [Related]
5. Comparison of technetium-99m-HM-PAO leukocytes with indium-111-oxine leukocytes for localizing intraabdominal sepsis.
Mountford PJ; Kettle AG; O'Doherty MJ; Coakley AJ
J Nucl Med; 1990 Mar; 31(3):311-5. PubMed ID: 2106576
[TBL] [Abstract][Full Text] [Related]
6. In vitro comparison of equine granulocytes labeled with 99mTc-hexamethylpropyleneamine oxime or 111In-oxine.
Daniel GB; Tucker RL; Buckman T; Daniel SL
Am J Vet Res; 1992 Jun; 53(6):871-6. PubMed ID: 1626776
[TBL] [Abstract][Full Text] [Related]
7. Abdominal scintigraphy using 99mTc-HMPAO-labelled leucocytes in patients with seronegative spondylarthropathies without clinical evidence of inflammatory bowel disease.
Alonso JC; Lopez-Longo FJ; Lampreave JL; González CM; Vegazo O; Carreño L; Almoguera I
Eur J Nucl Med; 1996 Mar; 23(3):243-6. PubMed ID: 8599954
[TBL] [Abstract][Full Text] [Related]
8. Leucocyte radiolabelling techniques: practical aspects.
Frier M
Scand J Gastroenterol Suppl; 1994; 203():32-5. PubMed ID: 7973446
[TBL] [Abstract][Full Text] [Related]
9. 99Tcm and 111In leucocyte scintigraphy in inflammatory bowel disease.
Li DJ; Middleton SJ; Wraight EP
Nucl Med Commun; 1992 Dec; 13(12):867-70. PubMed ID: 1465269
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory bowel disease activity assessment using technetium-99m-HMPAO leukocytes.
Arndt JW; Grootscholten MI; van Hogezand RA; Griffioen G; Lamers CB; Pauwels EK
Dig Dis Sci; 1997 Feb; 42(2):387-93. PubMed ID: 9052524
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous administration of 111In-human immunoglobulin and 99mTc-HMPAO labelled leucocytes in inflammatory bowel disease.
Mairal L; de Lima PA; Martin-Comin J; Baliellas C; Xiol X; Roca M; Ricart Y; Ramos M
Eur J Nucl Med; 1995 Jul; 22(7):664-70. PubMed ID: 7498228
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of white cell scintigraphy using indium-111 and technetium-99m labelled leucocytes.
Boyd SJ; Nour R; Quinn RJ; McKay E; Butler SP
Eur J Nucl Med; 1993 Mar; 20(3):201-6. PubMed ID: 8462607
[TBL] [Abstract][Full Text] [Related]
13. Comparison of 99Tcm-HMPAO and 111In-oxine labelled granulocytes in man: first clinical results.
Becker W; Schomann E; Fischbach W; Börner W; Gruner KR
Nucl Med Commun; 1988 Jun; 9(6):435-47. PubMed ID: 3137513
[TBL] [Abstract][Full Text] [Related]
14. Comparison of chemotaxis and superoxide generation of indium-111-oxine- and technetium-99m-HMPAO-labelled granulocytes.
Stoeckli TC; Zimmerli W; Maecke HR; Fridrich R
Scand J Clin Lab Invest; 1996 Jul; 56(4):305-9. PubMed ID: 8837236
[TBL] [Abstract][Full Text] [Related]
15. Prospective comparative study of technetium-99m-WBCs and indium-111-granulocytes for the examination of patients with inflammatory bowel disease.
Arndt JW; van der Sluys Veer A; Blok D; Griffoen G; Verspaget HW; Lamers CB; Pauwels EK
J Nucl Med; 1993 Jul; 34(7):1052-7. PubMed ID: 8315478
[TBL] [Abstract][Full Text] [Related]
16. Active inflammatory bowel disease: head-to-head comparison between 99mTc-hexamethylpropylene amine oxime white blood cells and 99mTc(V)-dimercaptosuccinic acid scintigraphy.
Stathaki MI; Koutroubakis IE; Koukouraki SI; Karmiris KP; Moschandreas JA; Kouroumalis EA; Karkavitsas NS
Nucl Med Commun; 2008 Jan; 29(1):27-32. PubMed ID: 18049094
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of endoscopy, radiology and scintigraphy with Tc-99m-exametazine labeled leukocytes and In-111 labeled human polyclonal immunoglobulin G in the diagnosis of inflammatory bowel disease].
de Lima Ramos PA; Martín-Comin J; Muñoz A; Baliellas C; Vilar L; Roca M; Ramos M
Med Clin (Barc); 1998 Sep; 111(7):241-6. PubMed ID: 9789237
[TBL] [Abstract][Full Text] [Related]
18. Is it possible to assess disease activity of inflammatory bowel disease with scintigraphy?
Arndt JW; Grootscholten MI
Neth J Med; 1996 Feb; 48(2):49-52. PubMed ID: 8819798
[TBL] [Abstract][Full Text] [Related]
19. Labelled leukocytes for diagnosis of infectious diseases. Our experience in labelling and clinical usefulness.
Tagliabue L; Majoli C; Pajoro U; Musarra M; Di Leo C; Del Sole A; Bestetti A; Tarolo GL
Minerva Med; 2000; 91(11-12):267-74. PubMed ID: 11253707
[TBL] [Abstract][Full Text] [Related]
20. The utility of [99mTc]HMPAO-leukocytes for imaging infection.
Peters AM
Semin Nucl Med; 1994 Apr; 24(2):110-27. PubMed ID: 8023168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
